Pessary Market Size

Pessary Market Analysis

The pessary market is projected to grow with a CAGR of 8.87% during the forecast period.

The COVID-19 pandemic has had a substantial impact on the growth of the pessary market owing to the significant decline in manufacturing processes, restricted demand and supply, and restricted hospital visits to avoid contact with infectious people. The industry has witnessed a negative impact as most of the population defer prosthetic surgeries due to transportation restrictions and the fear of viral infection. This has also resulted in the postponement of procedures, which included vaginal insertion of pessary as well. However, with the resumed services and prosthetic procedures, the demand for pessaries for treating various pelvic floor disorders has increased, thus the studied market has witnessed significant growth and is expected to grow over the forecast period.

Factors such as the increasing prevalence of pelvic organ prolapse, urinary incontinence in patients, increasing adoption of non-invasive treatment options, changing women's lifestyles, and a rise in the geriatric population are boosting the growth of the pessary market.

The prevalence of urinary incontinence (UI) is higher in women and elderly patients and creates a negative impact on their quality of life, which is the key factor driving the growth of the market. Urinary incontinence is becoming more common among people due to aging-related changes in the lower urinary system, including decreased bladder capacity and fullness sensation, decreased detrusor muscle contraction rate, decreased pelvic floor muscle resistance, and increased residual urine volume. For instance, according to an article published in the National Library of Medicine (NLM), in August 2022, an estimated 423 million people experience some form of UI worldwide. Similarly, according to an article published in Scientific Reports, in October 2022, it has been observed that the risk of UI increases with the first birth age, greater than 32, and decreases if the first birth occurs before age 32. Also, as per the same source, the prevalence of UI ranges between 5% to 70% during pregnancy and the postnatal period. Thus, the high prevalence of UI increases the demand for pessaries, thereby increasing the market's growth.

In addition, the increasing incidences of pelvic organ prolapse in females contribute to the pessary market's growth. The incidences of pelvic organ prolapse increase with age and after multiple pregnancies. According to an article published in Scientific Reports, in June 2022, pelvic floor disorders (PFD) which include UI, pelvic organ prolapse (POP), and bowel dysfunction (difficult defecation and anal incontinence (AI)) are common among adult women seeing in primary care settings. It has been observed that bowel dysfunction was the most prevalent PFD among women, accounting for 24.6% of all cases, followed by urine incontinence (11.1%) and pelvic organ prolapse (POP) (4.4%) in Iowa. Additionally, as per the same source, about 1.1% had all three categories of PFD, and 5.5% had precisely two PFD. Thus, the high prevalence of pelvic organ prolapse in women increases the demand for pessaries to treat pelvic organ prolapse issues in women, thereby contributing to the market growth.

Therefore, owing to the aforementioned factors, such as the high burden of urinary incontinence and pelvic organ prolapse, the studied market is anticipated to grow over the forecast period. However, patient discomfort and fear of side effects are some factors that hinder the market's growth.